ACN vs COYA · P/E 24, rev $17.60B vs rev $7.9M
Accenture plc (ACN) versus Coya Therapeutics, Inc. Common Stock (COYA) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. COYA currently screens at market cap $118.0M.
Not investment advice. Open the ACN and COYA stock pages for the full models.
Not investment advice.